Results

Total Results: 2,279 records

Showing results for "factor".

81. Peripheral Arterial Disease | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/peripheral-arterial-disease
    May 29, 2013 - The main risk factor for PAD is smoking.

82. Effective Health Care (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0496_12-30-2011.pdf
    January 01, 2011 - The most important risk factor for CIN, chronic kidney disease, is rising, driven in part by the increasing

83. Disposition of Comments Report for Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_disposition-comments.pdf
    March 07, 2012 - Disposition of Comments Report for Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated … Research Review Disposition of Comments Report Research Review Title: Antinuclear Antibody, Rheumatoid Factor … Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal … Similarly, I am not sure that the authors are familiar with modern tests for rheumatoid factor.

84. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
    December 20, 2011 - -32.mp. 7 bnp77-108.mp. 8 probnp.mp. 9 nt-probnp1-76.mp. 10 natriuretic factor … -32.tw. 7 bnp77-108.tw. 8 probnp.tw. 9 nt-probnp1-76.tw. 10 natriuretic factor … -32.tw. 7 bnp77-108.tw. 8 probnp.tw. 9 nt-probnp1-76.tw. 10 natriuretic factor … Prognostic Factor Measurement 3. … The prognostic factor of interest is adequately measured in study participants to sufficiently limit

85. Attention Deficit Hyperactivity Disorder | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/attention-deficit-hyperactivity-disorder
    April 10, 2025 - It sometimes runs in families, so genetics may be a factor.

86. Effective Health Care (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0075_03-10-2009.pdf
    January 01, 2009 - Aminosalicylates, corticosteroids, immune system suppressors, antibiotics, anti-diarrheals, anti-tumor necrosis factor

87. The Effectiveness of Disease-Modifying Antirheumatic Drugs (DMARDS) in Children With Juvenile Idiopathic Arthritis (JIA) | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/juvenile-arthritis-dmards/research-protocol
    December 01, 2019 - Polyarthritis: affects five or more joints during the first 6 months of disease; is subclassified as rheumatoid factor-negative … and rheumatoid factor-positive disease, the latter of which may be associated with more destructive … hepatotoxicity D-Penicillamine Depen Cuprimine unknown (may lower IgM rheumatoid factor … sensitivity analyses include: study quality, including the quality of the measurement of exposure to the factor … Settings RCTs Randomized Controlled Trials TEP Technical Expert Panel TNF Tumor Necrosis Factor

88. Effective Health Care (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0405_01-16-2011.pdf
    January 01, 2011 - Cough is also an important factor in the spread of infectious disease.

89. Esophagus Disorders | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/esophagus-disorders
    January 07, 2013 - Review Archived June 1, 2010 Comparative Effectiveness of In-Hospital Use of Recombinant Factor

90. Comparative Effectiveness of Core-Needle and Open Surgical Biopsy for the Diagnosis of Breast Lesions | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/breast-biopsy/research
    December 01, 2019 - intended to evaluate the accuracy of different methods of performing breast biopsy and to explore what factor

91. 08 Functional Limitations Potential High Impact 2012-12-10 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - Current therapies, specifically human factor VIIa (NovoSeven ® ) and Feiba ™ , work by bypassing the … VIII product that serves as factor VIII replacement therapy by activating the natural coagulation … OBI-1 is an intravenous, recombinant, porcine factor VIII product that serves as factor VIII replacement … reducing immunogenicity of the antigen to recombinant porcine factor VIII. … Study of modified recombinant factor VIII (OBI-1) in subjects with congenital hemophilia A.

92. Layout 1 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
    January 01, 2007 - Three biologics (adalimumab, etanercept, and infliximab) are also classified as anti-tumor necrosis factor … elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor … Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor … Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients … Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor

93. Stroke Prevention in Atr ial Fibr illation Patients: A Systematic Review (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stroke-afib-update_research-protocol-amended.pdf
    October 27, 2017 - Newer anticoagulants (direct oral anticoagulants [DOACs]) • Direct thrombin Inh-DTI: Dabigatran • Factor … Inhibitors"[Mesh] OR "Anticoagulants"[Pharmacological Action] OR "Factor Xa Inhibitors"[Pharmacological … Xa inhibitor"[tiab] OR "factor Xa inhibitors"[tiab] OR "Blood clotting inhibitor"[tiab] OR "blood … Inhibitors"[Mesh] OR "Anticoagulants"[Pharmacological Action] OR "Factor Xa Inhibitors"[Pharmacological … Xa inhibitor"[tiab] OR "factor Xa inhibitors"[tiab] OR "Blood clotting inhibitor"[tiab] OR "blood

94. Stroke-Atrial-Fibrillation Executive (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
    August 01, 2013 - has been identified by the Stroke Risk in Atrial Fibrillation Working Group as the strongest risk factor … IIa (thrombin) inhibitor dabigatran26 • ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa … • A factor IIa inhibitor (dabigatran) at a 110 mg dose is noninferior to warfarin for the composite … Factor IIa Inhibitor (Dabigatran 110 mg) vs. … For this evidence gap, we suggest focusing specifically on the comparative effectiveness of factor

95. Pressure Ulcer Risk Assessment and Prevention: A Comparative Effectiveness Review | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/pressure-ulcer-prevention/research-protocol
    December 01, 2019 - Sensitivity and Specificity"/ or "Reproducibility of Results"/ or "Severity of Illness Index"/ or (risk adj2 (factor … Curve/ 11 "Sensitivity and Specificity"/ 12 "Reproducibility of Results"/ 13 or/6-12 14 (risk adj2 (factor … Curve/ 11 "Sensitivity and Specificity"/ 12 "Reproducibility of Results"/ 13 or/6-12 14 (risk adj2 (factor … Reproducibility of Results") S13 (MH "ROC Curve") S14 S7 or S8 or S9 or S10 or S11 or S12 or S13 S15 "risk factor … Curve/ 11 "Sensitivity and Specificity"/ 12 "Reproducibility of Results"/ 13 or/6-12 14 (risk adj2 (factor

96. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
    March 01, 2017 - If changing a putative risk factor changes the cognitive course, it will be seen as more salient. … including nutrition, physical activity, cognitive training, social activity, and/or vascular risk factor … seeking to slow or prevent age- related cognitive decline, MCI, and CATD may have more than one risk factor … For example, obesity is a risk factor of concern but it can be studied only in the context of prevention … addressing nutrition, physical activity, cognitive training, social activity, and/or vascular risk factor

97. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
    March 01, 2017 - If changing a putative risk factor changes the cognitive course, it will be seen as more salient. … including nutrition, physical activity, cognitive training, social activity, and/or vascular risk factor … seeking to slow or prevent age- related cognitive decline, MCI, and CATD may have more than one risk factor … For example, obesity is a risk factor of concern but it can be studied only in the context of prevention … addressing nutrition, physical activity, cognitive training, social activity, and/or vascular risk factor

98. Microsoft Word - cognitive-decline-protocol-160322.docx (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
    March 22, 2016 - addressing nutrition, physical activity, cognitive training, social activity, and/or vascular risk factor … The etiology may involve more than one risk factor and interventions may have several components. … interventions for preventing dementia have looked at only the one-to-one relationship with a single risk factor … characteristics (i.e., age, sex, race/ethnicity, family history, education, socio-economic status, risk factor … characteristics (i.e., age, sex, race/ethnicity, family history, education, socio-economic status, risk factor

99. Juvenile-Arthritis-Dmards Surveillance (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective? … Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis-- data from the … Experiences with tumour necrosis factor- {alpha} inhibitors in patients with juvenile idiopathic arthritis … Subjects Primary Outcome Duration Findings Nakatani, 201113 Case report, methotrexate 1 Rheumatoid factor … RCT of etanercept+methotrexate (MTX)+prednisolone (arm 1) vs methotrexate (arm 2) 85 Rheumatoid factor

100. Juvenile-Arthritis-Dmards Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
     March 14, 2013 - Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective? … Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis-- data from the … Experiences with tumour necrosis factor- {alpha} inhibitors in patients with juvenile idiopathic arthritis … Subjects Primary Outcome Duration Findings Nakatani, 201113 Case report, methotrexate 1 Rheumatoid factor … RCT of etanercept+methotrexate (MTX)+prednisolone (arm 1) vs methotrexate (arm 2) 85 Rheumatoid factor